% Expired Patents = 100.0

EPO Patents = 2

Trademarks = 5

Forward Citations = 3

Loading Chart...

9 inventors (with patents filed for the assignee):

Dong-Ki Choi (3 out of 3 patents)

Yong-Sung Kim (2 out of 11 patents)

Sung-Hoon Kim (2 out of 157 patents)

4. Seung-Min Shin (2 out of 11 patents)

5. Ji Sun Kim (2 out of 33 patents)

6. Yong Sung Kim (2 out of 29 patents)

7. Jae Yeong Park (2 out of 2 patents)

8. Seong Wook Park (1 out of 1 patent)

9. Sei Yong Jun (1 out of 1 patent)

10. Dong Ki Choi (4 patents)

11. Sung Hoon Kim (102 patents)

12. Seung Min Shin (0 patent)

4 patents: Sort by Forward Citations

1. 11155641 - Cytosol-penetrating antibody and use thereof (2021-10-26),

2. 10851177 - Method for inhibiting intracellular activated RAS using intact immunoglobulin-type antibody having cytosol-penetrating ability and use thereof (2020-12-01),

3. 10844136 - Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for same (2020-11-24),

4. 10787487 - Cell/tissue-specific cell-penetrating antibodies (2020-09-29),

Company Overview

Orum Therapeutics Inc. is a biotechnology company focused on developing novel protein therapeutics for cancer and other diseases. Their proprietary technology platform enables the design of small proteins that can target intracellular protein-protein interactions, which are traditionally difficult to drug. Orum Therapeutics is dedicated to advancing breakthrough therapies through their innovative approach.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#122 in Daejeon

#2,200 in South Korea

Daejeon, South Korea

Orum Therapeutics Inc.

Forward Citations = 3

9 inventors:

Dong-Ki Choi (3 out of 3 patents)

Yong-Sung Kim (2 out of 11 patents)

Sung-Hoon Kim (2 out of 157 patents)

4. Seung-Min Shin (2 out of 11 patents)

5. Ji Sun Kim (2 out of 33 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Orum Therapeutics Inc.. Retrieved from https://idiyas.com/company/orum-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]